Canine parvovirus disease is an acute infectious disease caused by canine parvovirus (CPV). Current commercial vaccines are mainly attenuated and inactivated; as such, problems concerning safety may occur. To resolve this problem, researchers developed virus-like particles (VLPs) as biological nanoparticles resembling natural virions and showing high bio-safety. This property allows the use of VLPs for vaccine development and mechanism studies of viral infections. Tissue-specific drug delivery also employs VLPs as biological nanomaterials. Therefore, VLPs derived from CPV have a great potential in medicine and diagnostics. In this study, small ubiquitin-like modifier (SUMO) fusion motif was utilized to express a whole, naturalVP2 protein of CPV in Escherichia coli. After the cleavage of the fusion motif, the CPV VP2 protein has self-assembled into VLPs. The VLPs had a size and shape that resembled the authentic virus capsid. However, the self-assembly efficiency of VLPs can be affected by different pH levels and ionic strengths. The mice vaccinated subcutaneously with CPV VLPs and CPV-specific immune responses were compared with those immunized with the natural virus. This result showed that VLPs can effectively induce anti-CPV specific antibody and lymphocyte proliferation as a whole virus. This result further suggested that the antigen epitope of CPV was correctly present on VLPs, thereby showing the potential application of a VLP-based CPV vaccine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00253-013-5485-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevalence of common conditions and associated mortalities of dogs treated at the small animal clinic, Makerere University, Kampala, Uganda.
BMC Vet Res
December 2024
School of Statistics and Planning, Makerere University, Kampala, Uganda.
Background: In developing countries such as Uganda, domestic dogs suffer high burdens of infectious diseases often with high mortalities. Surveillance data on the common diseases and associated mortalities is however scanty. We thus, present results of a retrospective study of common clinical conditions and mortalities of dogs brought for treatment at the small animal clinic, Makerere University, Kampala, Uganda.
View Article and Find Full Text PDFChemical and Heat Treatment for Viral Inactivation in Porcine-Derived Gelatin.
BMC Biotechnol
December 2024
Biomedical Department, R&D Center, Nitta Gelatin Inc, 2-22, Futamata, Yao City, Osaka, 581-0024, Japan.
Article Synopsis
- - The study focuses on evaluating the effectiveness of virus inactivation methods used in the manufacturing process of porcine-derived gelatin, which is commonly used in pharmaceuticals and medical devices.
- - Researchers tested various model viruses and found that both chemical and heat treatments significantly reduced viral presence, achieving a log reduction value (LRV) greater than 4, indicating effective inactivation.
- - The findings confirm that implementing these treatment steps in gelatin production enhances safety by minimizing potential viral contamination in biomedical applications.
Detection and molecular epidemiology of canine parvovirus and identification of highly pathogenic CPV-2c isolates from Shandong, China.
Virus Genes
December 2024
College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, 266109, People's Republic of China.
Article Synopsis
- Canine parvovirus (CPV) is a serious virus affecting dogs and wild carnivores, with high mutation rates making it a challenging pathogen.
- A study in Shandong involved testing 62 samples from sick dogs, finding a 62.9% positivity rate for CPV, with the majority being subtype CPV-2c.
- Researchers identified new mutations in the virus that could affect how it interacts with hosts and its vaccine efficacy, and one particularly dangerous strain was isolated and found to be fatal to dogs in animal tests.
Molecular detection and quantification of canine parvovirus 2 using a fast and sensitive SYBR green-based quantitative polymerase chain reaction assay in dogs affected with gastroenteritis.
Vet World
October 2024
Facultad de Ciencias de la Salud, Carrera de Medicina Veterinaria, Universidad de Las Américas (UDLA), Quito, Ecuador, Antigua Vía a Nayón S/N, Quito EC 170124, Ecuador.
Background And Aim: Viral gastroenteritis in canines is primarily caused by the canine parvovirus 2 (CPV-2). Infections by this virus can cause severe consequences in dogs, such as fever, vomiting, diarrhea, septicemia, systemic inflammation, and immunosuppression. Therefore, the mortality rate of persistent infections caused by this virus is significantly high.
View Article and Find Full Text PDFCanine parvovirus NS1 induces host translation shutoff by reducing mTOR phosphorylation.
J Virol
November 2024
Guangdong Technological Engineering Research Center for Pets, College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.
Unlabelled: Canine parvovirus type 2 (CPV-2) is a member of the Parvoviridae family, characterized by its small, non-enveloped virions containing a linear single-stranded DNA genome of approximately 5 kb. Parvoviruses entirely reliant on the host cell's division machinery for replication. In this study, we demonstrate that CPV-2 infection triggers the host translation shutoff, a process in which the nonstructural protein 1 (NS1) plays a pivotal role.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!